Blastic Plasmacytoid Dendritic Cell

Common Name(s)

Blastic Plasmacytoid Dendritic Cell

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Blastic Plasmacytoid Dendritic Cell" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Blastic Plasmacytoid Dendritic Cell" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Blastic Plasmacytoid Dendritic Cell" returned 35 free, full-text research articles on human participants. First 3 results:

Spontaneous regression of cutaneous blastic plasmacytoid dendritic cell neoplasm followed by acute monocytic leukemia evolving from myelodysplastic syndrome.
 

Author(s): Hajime Yasuda, Tomoiku Takaku, Junichi Tomomatsu, Masaru Hosone, Hiroyuki Tanaka, Norio Komatsu

Journal: Intern. Med.. 2014 ;53(23):2717-20.

 

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive hematologic malignancy arising from plasmacytoid dendritic cell precursors. BPDCN typically manifests in the skin, but it can also evolve into a leukemic form or be complicated by acute myeloid leukemia, ...

Last Updated: 2 Dec 2014

Go To URL
A case of blastic plasmacytoid dendritic cell neoplasm with ecchymotic lesions on the whole body.
 

Author(s): Xiao-Bin Cui, Jing Jin, Xue-Lian Pang, Su Li, Chun-Xia Liu, Ting-Ting Li, Hao Peng, Shu-Mao Zhang, Li Li, Wei-Hua Liang, Yun-Zhao Chen, Feng Li

Journal:

 

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) derived from plasmacytoid dendritic cell precursors is a very rare, and characterized by cutaneous and bone marrow involvement and leukemic spread. The neoplasm presents with an aggressive behavior, and the clinical findings include ...

Last Updated: 14 Aug 2014

Go To URL
Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients.
 

Author(s): Arthur E Frankel, Jung H Woo, Chul Ahn, Naveen Pemmaraju, Bruno C Medeiros, Hetty E Carraway, Olga Frankfurt, Stephen J Forman, Xuezhong A Yang, Marina Konopleva, Francine Garnache-Ottou, Fanny Angelot-Delettre, Christopher Brooks, Michael Szarek, Eric Rowinsky

Journal: Blood. 2014 Jul;124(3):385-92.

 

This is the first prospective study of treatment of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN), an aggressive hematologic malignancy derived from plasmacytoid dendritic cells that typically involves the skin and rapidly progresses to a leukemia phase. Despite ...

Last Updated: 18 Jul 2014

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Blastic Plasmacytoid Dendritic Cell" returned 5 free, full-text review articles on human participants. First 3 results:

Blastic plasmacytoid dendritic cell neoplasm: update on molecular biology, diagnosis, and therapy.
 

Author(s): Wasif Riaz, Ling Zhang, Pedro Horna, Lubomir Sokol

Journal: Cancer Control. 2014 Oct;21(4):279-89.

 

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematological malignancy with an aggressive clinical course. Most patients with BPDCN have skin lesions and simultaneous involvement of the peripheral blood, bone marrow, and lymph nodes.

Last Updated: 14 Oct 2014

Go To URL
[Infant blastic plasmacytoid dendritic cell tumor: a case report and literature review].
 

Author(s): Jingjing Sun, Guangming Wang, Yun Pan

Journal: Zhonghua Xue Ye Xue Za Zhi. 2014 Jul;35(7):656-7.

 

Last Updated: 23 Jul 2014

Go To URL
Sustained complete remission of a limited-stage blastic plasmacytoid dendritic cell neoplasm followed by a simultaneous combination of low-dose DeVIC therapy and radiation therapy: a case report and review of the literature.
 

Author(s): Kei-Ji Sugimoto, Asami Shimada, Nanae Yamaguchi, Hidenori Imai, Mutsumi Wakabayashi, Yasunobu Sekiguchi, Hiroshi Izumi, Yasunori Ota, Norio Komatsu, Masaaki Noguchi

Journal:

 

The patient was a 74-year-old man who was found to have a cutaneous mass on his left shoulder in February 2012. Because the mass bled easily and was tending to grow, total resection of the cutaneous tumor, which measured approximately 5 cm x 3 cm, was performed in July. Histopathological ...

Last Updated: 14 Nov 2013

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in Genetics Home Reference.

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

SL-401 in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm or Acute Myeloid Leukemia
 

Status: Recruiting

Condition Summary: Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN); Acute Myeloid Leukemia

 

Last Updated: 11 Jun 2015

Go to URL
Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoma
 

Status: Recruiting

Condition Summary: Prolymphocytic Leukemia; Recurrent Adult Hodgkin Lymphoma; Recurrent Childhood Hodgkin Lymphoma; Recurrent Childhood Non-Hodgkin Lymphoma; Recurrent Chronic Lymphocytic Leukemia; Recurrent Non-Hodgkin Lymphoma; Recurrent Small Lymphocytic Lymphoma; Refractory Childhood Hodgkin Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Hodgkin Lymphoma; Refractory Non-Hodgkin Lymphoma; Refractory Small Lymphocytic Lymphoma; T-Cell Chronic Lymphocytic Leukemia; T-Cell Prolymphocytic Leukemia

 

Last Updated: 16 Jul 2015

Go to URL
Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies
 

Status: Recruiting

Condition Summary: Adult Acute Lymphoblastic Leukemia; Adult Acute Myeloid Leukemia; Adult Diffuse Large B-Cell Lymphoma; Aggressive Non-Hodgkin Lymphoma; Childhood Acute Lymphoblastic Leukemia; Childhood Acute Myeloid Leukemia; Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Childhood Diffuse Large B -Cell Lymphoma; DS Stage I Plasma Cell Myeloma; DS Stage II Plasma Cell Myeloma; DS Stage III Plasma Cell Myeloma; Myelodysplastic/Myeloproliferative Neoplasm; Prolymphocytic Leukemia; Refractory Childhood Hodgkin Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Stage I Adult Hodgkin Lymphoma; Stage I Aggressive Adult Non-Hodgkin Lymphoma; Stage I Childhood Hodgkin Lymphoma; Stage I Chronic Lymphocytic Leukemia; Stage I Diffuse Large B-Cell Lymphoma; Stage I Mantle Cell Lymphoma; Stage I Small Lymphocytic Lymphoma; Stage II Adult Hodgkin Lymphoma; Stage II Childhood Hodgkin Lymphoma; Stage II Chronic Lymphocytic Leukemia; Stage II Contiguous Adult Aggressive Non-Hodgkin Lymphoma; Stage II Contiguous Mantle Cell Lymphoma; Stage II Diffuse Large B-Cell Lymphoma; Stage II Non-Contiguous Aggressive Adult Non-Hodgkin Lymphoma; Stage II Non-Contiguous Mantle Cell Lymphoma; Stage II Small Lymphocytic Lymphoma; Stage III Adult Hodgkin Lymphoma; Stage III Aggressive Adult Non-Hodgkin Lymphoma; Stage III Childhood Hodgkin Lymphoma; Stage III Chronic Lymphocytic Leukemia; Stage III Diffuse Large B-Cell Lymphoma; Stage III Mantle Cell Lymphoma; Stage III Small Lymphocytic Lymphoma; Stage IV Adult Hodgkin Lymphoma; Stage IV Aggressive Adult Non-Hodgkin Lymphoma; Stage IV Childhood Hodgkin Lymphoma; Stage IV Chronic Lymphocytic Leukemia; Stage IV Diffuse Large B-Cell Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Small Lymphocytic Lymphoma; T-Cell Prolymphocytic Leukemia; Waldenstrom Macroglobulinemia

 

Last Updated: 14 Jul 2015

Go to URL